Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
RATIONALE: Diagnostic procedures such as thoracoscopy may help to measure a patient's response to previous treatment. PURPOSE: Diagnostic trial to determine the accuracy of thoracoscopy in patients who have stage IIIA non-small cell lung cancer.
Checked against the public recordLast updated Jul 14, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Alliance for Clinical Trials in Oncology
- Interventions being studied
- Procedure: videothoracoscopy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
1. Histologic Documentation: All patients must have histologic documentation of Stage IIIA non-small cell lung cancer on the basis of involved N2 nodes from a documented mediastinoscopy performed prior to induction therapy. Previously treated relapsed patients are not eligible. 2. Prior Treatment: greater than or equal to 2 cycles of chemotherapy with or without radiotherapy (greater than or equal to 40 Gy) or radiotherapy alone (greater than or equal to 40 Gy) must be completed within 60 days of registration. 3. No distant metastatic disease or local disease progression. Patients with responding or stable local disease are eligible. Those with local disease progression defined as a 25% increase in local tumor size or the appearance of new areas of malignant disease are ineligible. 4. No previous intrapleural surgery on the ipsilateral side. 5. ECOG Performance Status: 0-2
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Northeast Alabama Regional Medical CenterAnniston, Alabama
- Rebecca and John Moores UCSD Cancer CenterLa Jolla, California
- Veterans Affairs Medical Center - San DiegoSan Diego, California
- UCSF Comprehensive Cancer CenterSan Francisco, California
- Veterans Affairs Medical Center - San FranciscoSan Francisco, California
- CCOP - Christiana Care Health ServicesNewark, Delaware
- Lombardi Cancer CenterWashington D.C., District of Columbia
- Walter Reed Army Medical CenterWashington D.C., District of Columbia
- Veterans Affairs Medical Center - Washington, DCWashington D.C., District of Columbia
- Broward General Medical CenterFort Lauderdale, Florida
- Memorial Regional Hospital Comprehensive Cancer CenterHollywood, Florida
- CCOP - Mount Sinai Medical CenterMiami Beach, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 14, 2016. Always confirm current availability with the study team.